Back

Role of beta-3 adrenergic receptor polymorphism TRY64ARG in heart failure.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Pathophysiology of heart failure: basic mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Gian Manuel Jimenez Rodriguez

Instituto Nacional de Cardiologia Ignacio Chavez, Ciudad de Mexico (Mexico)

7 More presentations in this session

Presentation thumbnail
Genome-wide association study of heart failure in a multiethnic south-east asian cohort
Mr S. Loong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
IkBz is an inhibitor of the serine/threonine kinase and liquid-liquid phase separation that causes transition from adaptive cardiac hypertrophy to heart failure during pressure overload
Assistant Professor Y. Tanaka (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
Histidine triad nucleotide-binding protein 2 deficiency induce myocardial glucose utilization disorder in mice
Doctor M. Fan (Nantong, CN)
Abstract Slides Video
Presentation thumbnail
Increased clonal hematopoiesis mutational burden and accelerated dynamic evolution of circulating clones in patients with ischemic heart failure.
Doctor K. Kirschbaum (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Modeling cardiac injury using human cardiac slices to test therapeutic approaches for cardiac regeneration and repair
Doctor A. Lodrini (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology of heart failure: basic mechanisms

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources